Literature DB >> 10069640

Relative risk of malignant tumors in analgesic abusers. Effects of long-term intake of aspirin.

C Bucher1, P Jordan, V Nickeleit, J Torhorst, M J Mihatsch.   

Abstract

BACKGROUND: Nonsteroidal anti-inflammatory drugs (NSAID) e.g. aspirin, indomethacin are reported in epidemiological and experimental studies to reduce the risk for colo-rectal cancer and potentially other malignant tumors.
METHODS: We examined the effect of NSAIDs on tumor prevalence in abusers of mixed analgesics containing aspirin, phenacetine, caffeine or codein. 618 analgesic abusers who were autopsied between 1968-1983 were compared with a control group without evidence of analgesic abuse matched for sex, age and year autopsy was performed. RESULTS AND
CONCLUSIONS: Abusers were found to have an overall risk of 0.40 fold of having developed a malignancy as compared with the controls. Excluding patients with urinary tract tumors which are increased in analgesic abusers the risk was further decreased to 0.28. No statistically significant effect was found for patients with prostate cancer. The results encourage prospective control studies in high risk patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10069640

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  7 in total

1.  [Eulogy to Prof. Dr. Med. Michael J. Mihatsch : Presentation of the Rudolf Virchow Medal 2019 of the German Society of Pathology].

Authors:  H Moch
Journal:  Pathologe       Date:  2019-12       Impact factor: 1.011

Review 2.  NSAIDs and gastrointestinal cancer prevention.

Authors:  Kate Jolly; Kar K Cheng; Michael J S Langman
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 3.  Local endocrine, paracrine and redox signaling networks impact estrogen and androgen crosstalk in the prostate cancer microenvironment.

Authors:  Melanie J Grubisha; Donald B DeFranco
Journal:  Steroids       Date:  2013-02-01       Impact factor: 2.668

4.  Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis.

Authors:  Antonio González-Pérez; Luis A García Rodríguez; Ruy López-Ridaura
Journal:  BMC Cancer       Date:  2003-10-31       Impact factor: 4.430

5.  COX-2 expression positively correlates with PD-L1 expression in human melanoma cells.

Authors:  Gerardo Botti; Federica Fratangelo; Margherita Cerrone; Giuseppina Liguori; Monica Cantile; Anna Maria Anniciello; Stefania Scala; Crescenzo D'Alterio; Chiara Trimarco; Angela Ianaro; Giuseppe Cirino; Corrado Caracò; Maria Colombino; Giuseppe Palmieri; Stefano Pepe; Paolo Antonio Ascierto; Francesco Sabbatino; Giosuè Scognamiglio
Journal:  J Transl Med       Date:  2017-02-23       Impact factor: 5.531

Review 6.  Prostate cancer and use of nonsteroidal anti-inflammatory drugs: systematic review and meta-analysis.

Authors:  S Mahmud; E Franco; A Aprikian
Journal:  Br J Cancer       Date:  2004-01-12       Impact factor: 7.640

7.  Cyclooxygenase 2 (COX2) and Peroxisome Proliferator-Activated Receptor Gamma (PPARG) Are Stage-Dependent Prognostic Markers of Malignant Melanoma.

Authors:  Stefanie Meyer; Thomas Vogt; Michael Landthaler; Anna Berand; Albrecht Reichle; Frauke Bataille; Andreas H Marx; Anne Menz; Arndt Hartmann; Leoni A Kunz-Schughart; Peter J Wild
Journal:  PPAR Res       Date:  2009-07-20       Impact factor: 4.964

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.